Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-104-4 | CAS number: 60207-90-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 Apr 2017 to 08 May 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole
- EC Number:
- 262-104-4
- EC Name:
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole
- Cas Number:
- 60207-90-1
- Molecular formula:
- C15H17Cl2N3O2
- IUPAC Name:
- 1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole
Constituent 1
Method
- Target gene:
- his- (S. typhimurium), trp- (E. coli)
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- Source of S9: liver preparations (S9 mix) from rats treated with phenobarbital and 5,6-benzoflavone - Test concentrations with justification for top dose:
- Experiment I: 5; 15; 50; 150; 500; 1500; and 5000 µg/plate
Experiment II: 5; 15; 50; 150; 500; 1500; and 5000 µg/plate - Vehicle / solvent:
- - Solvent used: DMSO
- Justification for choice of solvent:
The solubility of test substance was assessed at 50 mg/mL in dimethyl sulfoxide (DMSO), in which it dissolved. DMSO was, therefore, used as the vehicle for this study.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: three
- Number of independent experiments : two
METHOD OF TREATMENT:
- Cell density at seeding: 10^9/mL
- Test substance added in medium (Experiment 1) and by preincubation (Experiment 2)
TREATMENT AND HARVEST SCHEDULE:
- Experiment 1 Plate incubation method: Aliquots of 0.1 mL of the test item solutions (seven concentrations up to 5000 µg/plate), positive control or vehicle control were placed in glass tubes. The vehicle control was DMSO. S9 mix (0.5 mL) or 0.1 M pH 7.4 sodium phosphate buffer (0.5 mL) was added, followed by 0.1 mL of a 10-hour bacterial culture and 2 mL of agar containing histidine (0.05 mM), biotin (0.05 mM) and tryptophan (0.05 mM). The mixture was thoroughly shaken and overlaid onto previously prepared Petri dishes containing 25 mL minimal agar.
- Experiment 2 Preincubation method: As a clear negative response was obtained in the first experiment, a variation to the test procedure was used for the second experiment. The variation used was the pre-incubation assay in which the tubes, which contained mixtures of bacteria, buffer or S9 mix and test dilution, were incubated at 34 to 39°C for 30 minutes with shaking before the addition of the agar overlay. The maximum concentration chosen was again 5000 µg/plate.
- Exposure duration: 48 hours
FOR GENE MUTATION:
- All plates were incubated at approximately 34 to 39 °C at least 48 hours. After this period, the appearance of the background bacterial lawn was examined and revertant colonies counted using an automated colony counter (Perceptive Instruments Sorcerer)
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Any toxic effects of the test item may be detected by a substantial reduction in mean revertant colony counts, by a sparse or absent background bacterial lawn, or both. - Evaluation criteria:
- If exposure to a test item produces a reproducible increase in mean revertant colony numbers of at least twice that of the concurrent vehicle controls, with some evidence of a positive concentration-response relationship, it is considered to exhibit mutagenic activity in this test system.
If exposure to a test item does not produce a reproducible increase in mean revertant colony numbers, it is considered to show no evidence of mutagenic activity in this test system. No statistical analysis is performed additionally since this is not required by the guideline.
If the results obtained fail to satisfy the criteria for a clear "positive" or "negative" response, even after additional testing, the test data may be subjected to analysis to determine the statistical significance of any increases in revertant colony numbers. The statistical procedures used are those described by Mahon et al (1989) and are usually Dunnett's test followed, if appropriate, by trend analysis. Biological importance will be considered along with statistical significance. In general, treatment-associated increases in mean revertant colony numbers below two or three times those of the vehicle controls (as described above) are not considered biologically important - Statistics:
- The statistical procedures used are those described by Mahon et al (1989) and are usually Dunnett's test followed, if appropriate, by trend analysis.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- other: S. typhimurium
- Remarks:
- TA98, TA100, TA1535, TA1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Experiment 1 (Plate Incubation Assay)
Toxicity, observed as a thin or absent background lawn of non-revertant colonies and/or reduction in the number of revertant colonies, was obtained in strains TA100, TA1537 and WP2 uvrA (pKM101) following exposure to test substance and in strains TA98 and TA1535 in the presence of metabolic activation only. Precipitate was observed on all plates containing test substance at 5000 µg/plate in the absence of S9 mix. A maximum exposure concentration of 5000 µg/plate was, therefore, selected for use in the second experiment. No substantial increases in revertant colony numbers over control counts were obtained with any of the tester strains following exposure to test substance at any concentration up to and including 5000 µg/plate in either the presence or absence of S9 mix.
The revertant colony count seen in the vehicle control plates in strain WP2 uvrA (pKM101) in the presence of S9 mix were above the laboratory historical control data and therefore this was repeated.
Experiment 1 repeat (Plate Incubation Assay)
Toxicity, observed as a thin background lawn of non-revertant colonies, was obtained in strain WP2 uvrA (pKM101) following exposure to test substance. No precipitate was observed on plates containing test substance. No substantial increases in revertant colony numbers over control counts were obtained with
any of the tester strains following exposure to test substance at any concentration up to and including 5000 µg/plate in the presence of S9 mix.
Experiment 2 (Pre-incubation Assay)
Toxicity, observed as a thin or absent background lawn of non-revertant colonies and/or reduction in the number of revertant colonies, was obtained in strains TA98, TA100, TA1535, TA1537 and WP2 uvrA (pKM101) following exposure to test substance. Precipitate was observed on all plates containing test substance at 5000 µg/plate in the absence of S9 mix.
No substantial increases in revertant colony numbers over control counts were obtained with any of the tester strains following exposure to test substance at any concentration up to and including 5000 µg/plate in either the presence or absence of S9 mix. An insufficient number of non-toxic concentrations was achieved in strains TA100 and TA1537 in the absence of S9 mix therefore these were repeated with a modified concentration range.
Experiment 2 repeat (Pre-incubation Assay)
Toxicity, observed as a thin or absent background lawn of non-revertant colonies and/or reduction in the number of revertant colonies, was obtained in strains TA100 and TA1537 following exposure to test substance in the absence of S9 mix. No precipitate was observed on plates containing test substance.
No substantial increases in revertant colony numbers over control counts were obtained with any of the tester strains following exposure to test substance at any concentration up to and including 5000 µg/plate in the absence of S9 mix.
Please, see 'Any other information on results incl. tables'
Any other information on results incl. tables
Table 1. Results Obtained in the Absence of Metabolic Activation: Experiment 1.
Strain |
Addition |
Concentration per plate (µg) |
Mean revertants per plate |
SD |
Fold increase relative to vehicle |
Individual revertant colony counts |
TA98 |
DMSO |
|
22.7 |
9.3 |
|
33, 20, 15 |
|
Test subst. |
5 |
22 |
3.5 |
1 |
24, 18, 24 |
|
|
15 |
32.7 |
5.5 |
1.4 |
38, 27, 33 |
|
|
50 |
23.7 |
3.5 |
1 |
24, 27, 20 |
|
|
150 |
25.3 |
8.1 |
1.1 |
24, 18, 34 |
|
|
500 |
24.7 |
3.8 |
1.1 |
23, 29, 22 |
|
|
1500 |
22 |
7 |
1 |
29, 22, 15 |
|
|
5000 |
19 |
5.2 |
0.8 |
13 S P, 22 S P, 22 S P |
TA100 |
DMSO |
|
172 |
19.2 |
|
194, 163, 159 |
|
Test subst. |
5 |
179.7 |
17.4 |
1 |
160, 193, 186 |
|
|
15 |
191 |
5.2 |
1.1 |
188, 188, 197 |
|
|
50 |
182 |
15.6 |
1.1 |
200, 172, 174 |
|
|
150 |
163.3 |
2.5 |
0.9 |
161, 166, 163 |
|
|
500 |
164.3 |
11.4 |
1 |
177, 161, 155 |
|
|
1500 |
123.3 |
13.6 |
0.7 |
139 T, 115 T, 116 T |
|
|
5000 |
49 |
14.8 |
0.3 |
59 P V, 56 P V, 32 P V |
TA1535 |
DMSO |
|
24.3 |
3.8 |
|
27, 26, 20 |
|
Test subst. |
5 |
23.3 |
7.1 |
1 |
22, 31, 17 |
|
|
15 |
27.3 |
1.5 |
1.1 |
26, 27, 29 |
|
|
50 |
21.7 |
4.7 |
0.9 |
27, 20, 18 |
|
|
150 |
20 |
4.6 |
0.8 |
21, 24, 15 |
|
|
500 |
20 |
3.6 |
0.8 |
21, 23, 16 |
|
|
1500 |
18.7 |
8.1 |
0.8 |
26, 10, 20 |
|
|
5000 |
14.7 |
5.7 |
0.6 |
10 S P, 21 S P, 13 S P |
TA1537 |
DMSO |
|
9.7 |
3.2 |
|
6, 12, 11 |
|
Test subst. |
5 |
11.3 |
4.5 |
1.2 |
7, 11, 16 |
|
|
15 |
10.3 |
0.6 |
1.1 |
11, 10, 10 |
|
|
50 |
9 |
2.6 |
0.9 |
6, 10, 11 |
|
|
150 |
9.7 |
0.6 |
1 |
10, 9, 10 |
|
|
500 |
8 |
2.6 |
0.8 |
5, 9, 10 |
|
|
1500 |
10.7 |
3.2 |
1.1 |
7, 12, 13 |
|
|
5000 |
10.7 |
5.1 |
1.1 |
5 S P, 12 S P, 15 S P |
WP2 uvrA |
DMSO |
|
238.3 |
12.7 |
|
227, 236, 252 |
|
Test subst. |
5 |
238.3 |
15.3 |
1 |
225, 255, 235 |
|
|
15 |
220 |
6.6 |
0.9 |
221, 226, 213 |
|
|
50 |
230.7 |
18.1 |
1 |
244, 210, 238 |
|
|
150 |
243.7 |
7 |
1 |
237, 243, 251 |
|
|
500 |
233.3 |
10 |
1 |
241, 237, 222 |
|
|
1500 |
222.3 |
4.2 |
0.9 |
221, 227, 219 |
|
|
5000 |
238.7 |
6.7 |
1 |
223 S P, 24 S P 6, 237 S P |
TA98 |
2NF |
2 |
265 |
76.3 |
11.7 |
353, 218, 224 |
TA100 |
NaN3 |
2 |
775.3 |
87.6 |
4.5 |
804, 677, 845 |
TA1535 |
NaN3 |
2 |
796.3 |
66.4 |
32.7 |
769, 748, 872 |
TA1537 |
AAC |
50 |
158 |
57.7 |
16.3 |
220, 148, 106 |
WP2 uvrA |
NQO |
2 |
2775 |
596 |
11.6 |
2110, 3261, 2954 |
2NF – 2-Nitrofluorene
NaN3 – Sodium azide
AAC – 9-Aminoacridine
NQO – 4-Nitroquinoline-1-oxide
P – Precipitate
S – Slight thinning of bacterial lawn
T – Thinning of bacterial lawn
V – Severe thinning of bacterial lawn
Table 2. Results Obtained in the Presence of Metabolic Activation: Experiment 1.
Strain |
Addition |
Concentration per plate (µg) |
Mean revertants per plate |
SD |
Fold increase relative to vehicle |
Individual revertant colony counts |
TA98 |
DMSO |
|
32.7 |
5.5 |
|
38, 27, 33 |
|
Test subst. |
5 |
29 |
2.6 |
0.9 |
32, 27, 28 |
|
|
15 |
31.3 |
9.1 |
1 |
21, 38, 35 |
|
|
50 |
31.3 |
6.8 |
1 |
39, 29, 26 |
|
|
150 |
36.7 |
11.9 |
1.1 |
33, 27, 50 |
|
|
500 |
35.3 |
1.5 |
1.1 |
35, 34, 37 |
|
|
1500 |
27 |
2.6 |
0.8 |
24, 29, 28 |
|
|
5000 |
10 |
2.6 |
0.3 |
7 T, 11 T, 12 T |
TA100 |
DMSO |
|
210.7 |
10.2 |
|
215, 218, 199 |
|
Test subst. |
5 |
174 |
3 |
0.8 |
174, 177, 171 |
|
|
15 |
191 |
8 |
0.9 |
183, 199, 191 |
|
|
50 |
161.3 |
9.5 |
0.8 |
161, 171, 152 |
|
|
150 |
177.3 |
19.4 |
0.8 |
156, 182, 194 |
|
|
500 |
203.3 |
18.4 |
1 |
183, 208, 219 |
|
|
1500 |
99.7 |
28.3 |
0.5 |
115 V, 117 V, 67 V |
|
|
5000 |
0 |
0 |
0 |
0 V, 0 V, 0 V |
TA1535 |
DMSO |
|
14.3 |
2.1 |
|
16, 15, 12 |
|
Test subst. |
5 |
11 |
2 |
0.8 |
9, 11, 13 |
|
|
15 |
12.7 |
3.1 |
0.9 |
10, 16, 12 |
|
|
50 |
11 |
1 |
0.8 |
11, 12, 10 |
|
|
150 |
16.7 |
6.7 |
1.2 |
24, 11, 15 |
|
|
500 |
12.3 |
4.2 |
0.9 |
9, 11, 17 |
|
|
1500 |
15 |
6.9 |
1 |
23 S, 11 S, 11 S |
|
|
5000 |
9 |
3.6 |
0.6 |
12 T, 10 T, 5 T |
TA1537 |
DMSO |
|
10 |
3 |
|
13, 10, 7 |
|
Test subst. |
5 |
14.7 |
1.5 |
1.5 |
16, 15, 13 |
|
|
15 |
12 |
1 |
1.2 |
12, 13, 11 |
|
|
50 |
16 |
5 |
1.6 |
11, 16, 21 |
|
|
150 |
15 |
4.4 |
1.5 |
12, 20, 13 |
|
|
500 |
12.3 |
4.9 |
1.2 |
9, 10, 18 |
|
|
1500 |
5 |
1 |
0.5 |
6 S, 5 S, 4 S |
|
|
5000 |
0.3 |
0.6 |
0 |
0 V, 0 V, 1 V |
WP2 uvrA |
DMSO |
|
300.3 |
18.6 |
|
302, 281, 318 |
|
Test subst. |
5 |
338.3 |
35.5 |
1.1 |
373, 302, 340 |
|
|
15 |
332 |
14.1 |
1.1 |
319, 330, 347 |
|
|
50 |
326.7 |
21 |
1.1 |
343, 334, 303 |
|
|
150 |
292.7 |
23.1 |
1 |
290, 317, 271 |
|
|
500 |
301.7 |
16.5 |
1 |
288, 320, 297 |
|
|
1500 |
271 |
20 |
0.9 |
251 S, 271 S, 291 S |
|
|
5000 |
251 |
8.7 |
0.8 |
241 S, 257 S, 255 S |
TA98 |
B[a]P |
5 |
257 |
10.8 |
7.9 |
254, 269, 248 |
TA100 |
AAN |
5 |
4488 |
115.3 |
21.3 |
4402, 4443, 4619 |
TA1535 |
AAN |
5 |
360 |
13.5 |
25.1 |
346, 373, 361 |
TA1537 |
B[a]P |
5 |
59.3 |
20.6 |
5.9 |
50, 45, 83 |
WP2 uvrA |
AAN |
10 |
1708.3 |
106.4 |
5.7 |
1588, 1747, 1790 |
B[a]P – Benzo[a]pyrene
AAN – 2-Aminoanthracene
S – Slight thinning of bacterial lawn
T – Thinning of bacterial lawn
V – Severe thinning of bacterial lawn
Table 3. Results Obtained in the Presence of Metabolic Activation: Experiment 1 repeat
Strain |
Addition |
Concentration per plate (µg) |
Mean revertants per plate |
SD |
Fold increase relative to vehicle |
Individual revertant colony counts |
WP2 uvrA |
DMSO |
|
263 |
13.5 |
|
276, 264, 249 |
|
Test subst. |
5 |
231 |
42.3 |
0.9 |
192, 225, 276 |
|
|
15 |
227.3 |
8.6 |
0.9 |
235, 229, 218 |
|
|
50 |
229.3 |
16.3 |
0.9 |
218, 222, 248 |
|
|
150 |
247.3 |
7 |
0.9 |
254, 240, 248 |
|
|
500 |
245.3 |
2.9 |
0.9 |
247, 247, 242 |
|
|
1500 |
252.7 |
4.7 |
1 |
251 S, 249 S, 258 S |
|
|
5000 |
242 |
23 |
0.9 |
265 S, 242 S, 219 S |
|
AAN |
10 |
938.3 |
43.2 |
3.6 |
952, 973, 890 |
AAN – 2-Aminoanthracene
S – Slight thinning of bacterial lawn
Table 4. Results Obtained in the Absence of Metabolic Activation: Experiment 2.
Strain |
Addition |
Concentration per plate (µg) |
Mean revertants per plate |
SD |
Fold increase relative to vehicle |
Individual revertant colony counts |
TA98 |
DMSO |
|
20.3 |
2.1 |
|
22, 21, 18 |
|
Test subst. |
5 |
19.7 |
1.5 |
1 |
21, 20, 18 |
|
|
15 |
23 |
1.7 |
1.1 |
24, 24, 21 |
|
|
50 |
23 |
3 |
1.1 |
20, 23, 26 |
|
|
150 |
20.3 |
3.5 |
1 |
20, 24, 17 |
|
|
500 |
19 |
6.9 |
0.9 |
15 S, 27 S, 15 S |
|
|
1500 |
4.7 |
2.3 |
0.2 |
2 T, 6 T, 6 T |
|
|
5000 |
4 |
2.6 |
0.2 |
5 V P, 1 V P, 6 V P |
TA100 |
DMSO |
|
117.7 |
9.1 |
|
111, 128, 114 |
|
Test subst. |
5 |
139 |
17.4 |
1.2 |
127, 159, 131 |
|
|
15 |
151 |
14 |
1.3 |
167, 145, 141 |
|
|
50 |
151.7 |
8.1 |
1.3 |
143, 159, 153 |
|
|
150 |
62 |
36.4 |
0.5 |
40 V, 42 V, 104 V |
|
|
500 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
|
|
1500 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
|
|
5000 |
0 |
0 |
0 |
0 A P, 0 A P, 0 A P |
TA1535 |
DMSO |
|
15 |
2.6 |
|
17, 16, 12 |
|
Test subst. |
5 |
21.3 |
11.5 |
1.4 |
10, 33, 21 |
|
|
15 |
17.7 |
3.8 |
1.2 |
16, 22, 15 |
|
|
50 |
17.3 |
4 |
1.2 |
13, 21, 18 |
|
|
150 |
21.7 |
0.6 |
1.4 |
22, 22, 21 |
|
|
500 |
11 |
4.6 |
0.7 |
10 T, 16 T, 7 T |
|
|
1500 |
8 |
2.6 |
0.5 |
7 T, 6 T, 11 T |
|
|
5000 |
7 |
5.3 |
0.5 |
1 P V, 9 P V, 11 P V |
TA1537 |
DMSO |
|
9.3 |
3.5 |
|
6, 13, 9 |
|
Test subst. |
5 |
11.7 |
3.8 |
1.2 |
9, 10, 16 |
|
|
15 |
9.3 |
3.8 |
1 |
11, 12, 5 |
|
|
50 |
8.3 |
2.1 |
0.9 |
10, 9, 6 |
|
|
150 |
2.3 |
1.5 |
0.3 |
1 V, 2 V, 4 V |
|
|
500 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
|
|
1500 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
|
|
5000 |
0 |
0 |
0 |
0 A P, 0 A P, 0 A P |
WP2 uvrA |
DMSO |
|
192.3 |
14.8 |
|
176, 205, 196 |
|
Test subst. |
5 |
186.7 |
13 |
1 |
174, 186, 200 |
|
|
15 |
191.3 |
12.2 |
1 |
178, 194, 202 |
|
|
50 |
201 |
36.1 |
1 |
187, 174, 242 |
|
|
150 |
210.7 |
7.6 |
1.1 |
214, 216, 202 |
|
|
500 |
201.3 |
7.5 |
1 |
197, 210, 197 |
|
|
1500 |
215 |
36 |
1.1 |
208, 254, 183 |
|
|
5000 |
206.7 |
17.9 |
1.1 |
222 S P, 187 S P, 211 S P |
TA98 |
2NF |
2 |
163.7 |
54.4 |
8 |
199, 101, 191 |
TA100 |
NaN3 |
2 |
745 |
247.7 |
6.3 |
908, 867, 460 |
TA1535 |
NaN3 |
2 |
677 |
22.5 |
45.1 |
664, 664, 703 |
TA1537 |
AAC |
50 |
117.3 |
6.7 |
12.6 |
119, 110, 123 |
WP2 uvrA |
NQO |
2 |
2909.3 |
273.5 |
15.1 |
3173, 2627, 2928 |
2NF – 2-Nitrofluorene
NaN3 – Sodium azide
AAC – 9-Aminoacridine
NQO – 4-Nitroquinoline-1-oxide
P – Precipitate
S – Slight thinning of bacterial lawn
T – Thinning of bacterial lawn
V – Severe thinning of bacterial lawn
Table 5. Results Obtained in the Presence of Metabolic Activation: Experiment 2.
Strain |
Addition |
Concentration per plate (µg) |
Mean revertants per plate |
SD |
Fold increase relative to vehicle |
Individual revertant colony counts |
TA98 |
DMSO |
|
20.7 |
3.1 |
|
18, 24, 20 |
|
Test subst. |
5 |
22.7 |
4.5 |
1.1 |
23, 18, 27 |
|
|
15 |
24 |
6.1 |
1.2 |
27, 17, 28 |
|
|
50 |
21 |
1 |
1 |
21, 20, 22 |
|
|
150 |
22 |
2 |
1.1 |
20, 22, 24 |
|
|
500 |
21.7 |
5.9 |
1 |
15 T, 24 T, 26 T |
|
|
1500 |
18 |
3.6 |
0.9 |
22 T, 17 T, 15 T |
|
|
5000 |
8 |
1.7 |
0.4 |
9 V, 6 V, 9 V |
TA100 |
DMSO |
|
134 |
6.1 |
|
127, 137, 138 |
|
Test subst. |
5 |
134 |
3.6 |
1 |
131, 138, 133 |
|
|
15 |
156 |
3.5 |
1.2 |
154, 160, 154 |
|
|
50 |
150.3 |
8.7 |
1.1 |
143, 148, 160 |
|
|
150 |
144 |
22.6 |
1.1 |
165, 120, 147 |
|
|
500 |
93.7 |
15.7 |
0.7 |
76 T, 99 T, 106 T |
|
|
1500 |
81.7 |
9.9 |
0.6 |
93 V, 77 V, 75 V |
|
|
5000 |
9.3 |
4 |
0.1 |
10 V, 5 V, 13 V |
TA1535 |
DMSO |
|
10.7 |
1.5 |
|
9, 12, 11 |
|
Test subst. |
5 |
14.7 |
4.7 |
1.4 |
20, 13, 11 |
|
|
15 |
20 |
7.2 |
1.9 |
26, 22, 12 |
|
|
50 |
7.7 |
2.1 |
0.7 |
7, 6, 10 |
|
|
150 |
13.7 |
2.1 |
1.3 |
13, 16, 12 |
|
|
500 |
14.7 |
3.5 |
1.4 |
11, 18, 15 |
|
|
1500 |
7 |
2 |
0.7 |
7 S, 5 S, 9 S |
|
|
5000 |
8.7 |
6.5 |
0.8 |
2 T, 15 T, 9 T |
TA1537 |
DMSO |
|
7.7 |
2.1 |
|
10, 6, 7 |
|
Test subst. |
5 |
10.3 |
5.1 |
1.3 |
6, 16, 9 |
|
|
15 |
8.7 |
2.3 |
1.1 |
6, 10, 10 |
|
|
50 |
11.3 |
4.7 |
1.5 |
15, 6, 13 |
|
|
150 |
9.3 |
2.1 |
1.2 |
7, 10, 11 |
|
|
500 |
6.7 |
5 |
0.9 |
2 T, 12 T, 6 T |
|
|
1500 |
3.7 |
3.2 |
0.5 |
0 V, 5 V, 6 V |
|
|
5000 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
WP2 uvrA |
DMSO |
|
268 |
19.3 |
|
260, 254, 290 |
|
Test subst. |
5 |
260 |
14.7 |
1 |
252, 277, 251 |
|
|
15 |
264.7 |
10 |
1 |
264, 255, 275 |
|
|
50 |
253.3 |
18.5 |
0.9 |
263, 232, 265 |
|
|
150 |
255.3 |
4.5 |
1 |
260, 255, 251 |
|
|
500 |
255.3 |
22.2 |
1 |
281, 243, 242 |
|
|
1500 |
249 |
11.1 |
0.9 |
259 S, 251 S, 237 S |
|
|
5000 |
231.3 |
19.4 |
0.9 |
248 S, 210 S, 236 S |
TA98 |
B[a]P |
5 |
220 |
6.6 |
10.6 |
213, 226, 221 |
TA100 |
AAN |
5 |
2970.3 |
275.6 |
22.2 |
2659, 3183, 3069 |
TA1535 |
AAN |
5 |
260.7 |
17.6 |
24.4 |
263, 277, 242 |
TA1537 |
B[a]P |
5 |
59.3 |
3.8 |
7.7 |
62, 55, 61 |
WP2 uvrA |
AAN |
10 |
1485.3 |
77 |
5.5 |
1404, 1495, 1557 |
B[a]P – Benzo[a]pyrene
AAN – 2-Aminoanthracene
S – Slight thinning of bacterial lawn
T – Thinning of bacterial lawn
V – Severe thinning of bacterial lawn
Table 6. Results Obtained in the Absence of Metabolic Activation: Experiment 2 repeat.
Strain |
Addition |
Concentration per plate (µg) |
Mean revertants per plate |
SD |
Fold increase relative to vehicle |
Individual revertant colony counts |
TA100 |
DMSO |
|
165.3 |
5.9 |
|
172, 161, 163 |
|
Test subst. |
0.5 |
137 |
10.8 |
0.8 |
128, 134, 149 |
|
|
1.5 |
176.7 |
13.3 |
1.1 |
169, 169, 192 |
|
|
5 |
158 |
20.7 |
1 |
152, 141, 192 |
|
|
15 |
163.3 |
10.4 |
1 |
155, 175, 160 |
|
|
50 |
153 |
14.5 |
0.9 |
167, 154, 138 |
|
|
150 |
119.7 |
26.2 |
0.7 |
144 V, 123 V, 92 V |
|
|
500 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
TA1535 |
DMSO |
|
11.7 |
2.9 |
|
10, 15, 10 |
|
Test subst. |
0.5 |
8 |
3.5 |
0.7 |
10, 4, 10 |
|
|
1.5 |
8.3 |
1.2 |
0.7 |
9, 7, 9 |
|
|
5 |
10.7 |
2.1 |
0.9 |
13, 9, 10 |
|
|
15 |
11.3 |
4 |
1 |
15, 12, 7 |
|
|
50 |
10 |
5.6 |
0.9 |
9, 5, 16 |
|
|
150 |
1.7 |
0.6 |
0.1 |
2 V, 1 V, 2 V |
|
|
500 |
0 |
0 |
0 |
0 A, 0 A, 0 A |
TA100 |
NaN3 |
2 |
773.3 |
69.8 |
4.7 |
851, 753, 716 |
TA1535 |
AAC |
50 |
125.7 |
21.7 |
10.8 |
142, 101, 134 |
NaN3 – Sodium azide
AAC – 9-Aminoacridine
V – Severe thinning of bacterial lawn
A – Lawn absent
Applicant's summary and conclusion
- Conclusions:
- In this in vitro assessment of the mutagenic potential of the test substance performed in compliance with GLP and following the OECD 471 guideline, it was concluded that the test substance showed no evidence of mutagenic activity in this bacterial system under the test conditions employed.
- Executive summary:
In this in vitro assessment of the mutagenic potential of the test substance performed in compliance with GLP and following the OECD 471 guideline, histidine-dependent auxotrophic mutants of Salmonella typhimurium, strains TA1535, TA1537, TA98 and TA100, and a tryptophan-dependent mutant of Escherichia coli, strain WP2 uvrA (pKM101), were exposed to the test substance diluted in dimethyl sulfoxide (DMSO). DMSO was also used as a vehicle control. Two independent mutation experiments were performed in the presence and absence of liver preparations (S9 mix) from rats treated with phenobarbital and 5,6-benzoflavone. The first experiment was a standard plate incorporation assay; the second included a pre-incubation stage. Concentrations of the test substance up to 5000 µg/plate were tested. This is the standard limit concentration recommended in the regulatory guidelines that this assay follows. Other concentrations used were a series of ca half-log10 dilutions of the highest concentration.
Toxicity (observed as thinning of the background lawn of non-revertant colonies, and/or together with a reduction in revertant colony numbers) was seen in all strains following exposure to the test substance in both tests. Precipitate was observed on all plates containing the test substance at 5000 µg/plate in the absence of S9 mix in the first and second test. No evidence of mutagenic activity was seen at any concentration of the test substance in either experiment. The concurrent positive controls verified the sensitivity of the assay and the metabolizing activity of the liver preparations. The mean revertant colony counts for the vehicle controls were within or close to the current historical control range for the laboratory.
It was concluded that the test substance showed no evidence of mutagenic activity in this bacterial system under the test conditions employed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.